UK Fines Reckitt $16M For Thwarting Generic Meds
The U.K. Office of Fair Trading has fined Reckitt Benckiser Group PLC £10.2 million ($16.4 million) for withdrawing its National Health Service supply of Gaviscon heartburn medication in order to thwart...To view the full article, register now.
Already a subscriber? Click here to view full article